Uncategorized
What’s Going On With C3.AI Stock Tuesday?
C3.AI reported second-quarter revenue of $93.34 million, beating analyst estimates of $91.02 million, according to Benzinga Pro. The company reported a quarterly loss of 6 cents per share, beating analyst estimates for a loss of 16 cents per share. read more
Ferguson Maintains FY25 Guidance Amid Tough Market, Q1 Misses Estimates
FERG shares down after reporting Q1 results, with net sales of $7.77B, organic revenue down 0.3%, and adjusted EPS of $2.45. FY25 outlook reiterated. read more
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
Chimerix plans to submit an NDA for dordaviprone to treat H3 K27M-mutant glioma, with potential U.S. FDA approval targeted for late 2025. read more
